Showing results (521-530 of 607) with videos related to

Sort By:
Pageof 61
Pharmacoeconomics - Open|July 3, 2021
Non-Price-Related Determinants of Value and Access for Novel Non-small Cell Lung Cancer Treatments: A Cross-Country Review of HTA Decision MakingJason Gordon, Angela Stainthorpe, Beverley Jones, et al.
Pharmacoeconomics - Open|April 3, 2020
Is Protocolised Weaning that Includes Early Extubation Onto Non-Invasive Ventilation More Cost Effective Than Protocolised Weaning Without Non-Invasive Ventilation? Findings from the Breathe StudyIftekhar Khan, Mandy Maredza, Melina Dritsaki, et al.
Pharmacoeconomics - Open|September 30, 2020
Exploring Patient-Reported Costs Related to Hepatitis C on the Medical Crowdfunding Page GoFundMe®T Joseph Mattingly, Karen Li, Arnold Ng, et al.
Pharmacoeconomics - Open|November 15, 2020
The Actual Operative Costs of Liver Transplantation and Normothermic Machine Perfusion in a Canadian SettingAlexandria N Webb, Dayne L Izquierdo, Dean T Eurich, et al.
Pharmacoeconomics - Open|December 17, 2020
Cost Effectiveness of Nivolumab in Patients with Advanced, Previously Treated Squamous and Non-squamous Non-small-cell Lung Cancer in EnglandBen Rothwell, Christopher Kiff, Caroline Ling, et al.
Pharmacoeconomics - Open|June 16, 2021
Cost-Utility Analysis of Dolutegravir- Versus Efavirenz-Based Regimens as a First-Line Treatment in Adult HIV/AIDS Patients in EthiopiaYared Belete Belay, Eskinder Eshetu Ali, Karen Y Chung, et al.
Pharmacoeconomics - Open|July 9, 2021
Economic Evaluation of Transperineal versus Transrectal Devices for Local Anaesthetic Prostate BiopsiesEdward C F Wilson, Alice Wreford, Priya Tamer, et al.
Pharmacoeconomics - Open|July 5, 2022
How are Companion Diagnostics Considered in Economic Evaluations of Oncology Treatments? A Review of Health Technology AssessmentsMelissa Gomez Montero, Houcine El Alili, Mahmoud Hashim, et al.
Pharmacoeconomics - Open|May 5, 2022
Cost Analysis of Adjuvant Whole-Brain Radiotherapy Treatment Versus No Whole-Brain Radiotherapy After Stereotactic Radiosurgery and/or Surgery Among Adults with One to Three Melanoma Brain Metastases: Results from a Randomized TrialAnh Dam Tran, Angela M Hong, Mai T H Nguyen, et al.
Pharmacoeconomics - Open|July 23, 2021
Economic Model to Evaluate the Cost-Effectiveness of Second-Line Nilotinib Versus Dasatinib for the Treatment of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (CML-CP) in ItalyMassimiliano Bonifacio, Vikalp Maheshwari, Diana Tran, et al.
Pageof 61